Company intelligence / Profile preview

SWM International

Luxembourg City, Luxembourg

Ownership: Private
Employees: ~2000
Development stage: Other

Overview

Scapa Healthcare (an SWM business) partners with leading biotech and MedTech firms to supply and develop advanced wound care and medical fixation materials, using proprietary and licensed technologies (e.g., glycopolymer platform for wound care). Scapa has FDA 510(k)-cleared products and global manufacturing.

Therapeutic areas: OtherDermatology
Modalities: Hydrogel-based wound careAdvanced wound care materialsMedical device materialsPolymer-based medical components
Industry: Consumable Medical Devices

Partnerships

Synedgen (for glycopolymer wound care technology—exclusive worldwide license)Works with top global MedTech and pharma companies (confidential partners)

Beyond the preview

Go deeper on SWM International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SWM International.

Explore the full profile